Novus Therapeutics Inc (NASDAQ:NVUS)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - NVUS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - NVUS

  • Market Cap$20.920m
  • SymbolNASDAQ:NVUS
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS67011N1054

Company Profile

Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: Foam Platform(OP0201 and OP0202) and Surfactant Program(OP0201). OP0102 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP0201 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction.Novus Therapeutics Inc is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat products. Its technologies have the potential to be developed for multiple ENT indications.

Latest NVUS news

Currently there for this company. Visit our news hub for other news .